314 related articles for article (PubMed ID: 21057565)
1. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
El-Gendi S; Abdel-Hadi M
J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
[TBL] [Abstract][Full Text] [Related]
2. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?
Kandemir NO; Barut F; Bektas S; Ozdamar SO
Pathol Oncol Res; 2012 Apr; 18(2):253-62. PubMed ID: 21785902
[TBL] [Abstract][Full Text] [Related]
3. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
[TBL] [Abstract][Full Text] [Related]
4. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
[TBL] [Abstract][Full Text] [Related]
6. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
[TBL] [Abstract][Full Text] [Related]
7. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic microvessel density as prognostic marker in colorectal cancer.
Saad RS; Kordunsky L; Liu YL; Denning KL; Kandil HA; Silverman JF
Mod Pathol; 2006 Oct; 19(10):1317-23. PubMed ID: 16799477
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
Wahal SP; Goel MM; Mehrotra R
J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
[TBL] [Abstract][Full Text] [Related]
10. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers.
Kanngurn S; Thongsuksai P; Chewatanakornkul S
Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799
[TBL] [Abstract][Full Text] [Related]
11. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
Choi WW; Lewis MM; Lawson D; Yin-Goen Q; Birdsong GG; Cotsonis GA; Cohen C; Young AN
Mod Pathol; 2005 Jan; 18(1):143-52. PubMed ID: 15297858
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
14. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
15. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
16. The Akt expression correlates with the VEGF-A and -C expression as well as the microvessel and lymphatic vessel density in breast cancer.
Tsutsui S; Matsuyama A; Yamamoto M; Takeuchi H; Oshiro Y; Ishida T; Maehara Y
Oncol Rep; 2010 Mar; 23(3):621-30. PubMed ID: 20126999
[TBL] [Abstract][Full Text] [Related]
17. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
Shrivastav S; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma.
Guleria P; Srinivas V; Basannar D; Dutta V
Indian J Pathol Microbiol; 2018; 61(2):176-180. PubMed ID: 29676352
[TBL] [Abstract][Full Text] [Related]
19. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
